Tax risks and optimisation possibilities connected with marketing activities carried out by pharmaceutical companies
30-11--1 | Korneliusz Sawiński | kategoria: Doradztwo podatkowe
Many pharmaceutical companies have implemented ‘marketing procedures’, regulating, among others, the permissible ways, tools and channels for their advertising activities. Such procedures enable the company to take greater advantage of its marketing potential as well as to limit tax, legal and business risks inherent in the pharmaceutical industry. Notwithstanding the above, it is still crucial to monitor changes in tax law regulations as well as in the practice of tax courts and tax authorities, as they can result both in business opportunities and risks for pharmaceutical companies.
pobierz artykuł w formacie pliku PDF